Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anterix Inc. Director's Dealing 2020

Aug 20, 2020

33018_dirs_2020-08-19_4262df9f-b728-490e-8a71-f2c9472cb5d7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2020-08-18

Reporting Person: OBRIEN MORGAN E (Director, Executive Chairman)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-08-18 Common Stock M 3030 $20.00 Acquired 85621 Direct
2020-08-18 Common Stock S 3030 $44.761 Disposed 82591 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-08-18 Stock Option (Right to Buy) $20.00 M 3030 Disposed 2024-05-14 Common Stock (3030) Direct

Footnotes

F1: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and includes the sale of shares in order to cover tax liabilities in connection with the exercise of stock options.

F2: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $44.52 to $45.11. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F3: The option shares are fully vested.